HIVE Digital Technologies Ltd is a sustainable-energy-focused digital infrastructure company that provides infrastructure solutions through the operation of Tier-1 and Tier-3 data centers... Show more
HIVE Digital Technologies Ltd. builds and operates data centers powered by renewable energy, with facilities across Canada, Sweden, and Paraguay. The company pursues a "dual-engine" strategy: it mines Bitcoin while also operating a growing high-performance computing and AI cloud business through its BUZZ HPC subsidiary. HIVE is one of the first publicly listed Bitcoin miners to invest meaningfully in GPU cloud infrastructure, positioning it at the intersection of digital-asset mining and the AI buildout.
Investors follow HIVE for its exposure to both Bitcoin price dynamics and enterprise demand for AI compute. The company has secured notable contracts, including agreements with Bell Canada and AI firm Cohere, and has announced plans for a large AI data-center campus in the Greater Toronto Area. Led by Executive Chairman Frank Holmes and President and CEO Aydin Kilic, HIVE has grown contracted GPU cloud annual recurring revenue while expanding its operational hashrate.
Over the last 30 days, HIVE shares declined approximately 42.5%, falling from a closing price of $2.975 on October 2, 2026, to roughly $1.71 in early November 2026. The decline was largely persistent through October, with the stock posting a series of lower closes and reaching levels near the lower end of its 52-week range.
The move is part of a longer slide. Measured over the trailing quarter, HIVE fell roughly 41% from a closing level of about $2.89 in early August 2026. The trend has been broadly downward despite intermittent rebounds, indicating that short-term rallies have not yet reversed the underlying selling pressure.
Several verified factors weighed on HIVE shares during the period. Sentiment across Bitcoin miners softened, and industry coverage highlighted widening financing costs for AI infrastructure projects, with HIVE identified among miners facing potential funding gaps. Broader caution around the crypto-mining sector compounded the pressure.
A broker action added to the downside: Keefe Bruyette (KBW) lowered its price target on HIVE to $2.50 from $4.50 while maintaining a Market Perform rating. Insider activity also drew attention after a director sold shares. Concerns about dilution from the company's at-the-market equity programs and previously issued convertible notes remained a recurring theme in analyst commentary.
These headwinds overshadowed otherwise constructive announcements. In late October, HIVE's BUZZ HPC subsidiary secured approximately $129 million in fixed-rate financing at a 9.0% interest rate to expand sovereign AI infrastructure using NVIDIA (NVDA) GB200 GPUs. The company also disclosed a roughly $350 million, five-year GPU cloud agreement for Blackwell Ultra GPUs, lifting its contracted HPC run-rate. Despite this operational momentum, the stock continued to decline.
The quarterly decline reflects a broader repricing rather than a single event. Even as HIVE reported strong revenue growth, investors remained focused on profitability, financing costs, and dilution. For its fiscal first quarter of 2027, HIVE reported revenue of $79.1 million, up 73.5% year over year, but a net loss of $142.9 million that included a large non-cash provision of roughly $84.7 million tied to a contested value-added tax assessment from Swedish authorities.
Meanwhile, the market has weighed HIVE's transition toward AI infrastructure against the capital intensity of that shift. Competing miners such as IREN and Riot Platforms (RIOT) faced similar scrutiny over AI funding, reinforcing sector-wide caution. The net effect has been a steady compression in HIVE's valuation even as the company's contracted AI backlog expanded.
Tickeron offers hundreds of AI trading bots that trade thousands of tickers, but only the top-performing and most relevant strategies appear in its curated Trending AI Robots section. These bots vary in strategy, timeframe, and performance metrics, allowing traders to review automated approaches suited to different risk profiles and market conditions. The section is designed to help investors discover signal-driven tools and monitor which AI strategies are currently resonating. Explore the Trending AI Robots page to see the strategies gaining traction.
Investors should monitor HIVE's next earnings report, scheduled for mid-November 2026, for updates on mining margins, hashrate, and the pace of GPU cloud revenue growth. The company's ability to convert signed contracts into deployed capacity and reach its targeted annualized recurring revenue levels will be a key test of the AI strategy.
Broader variables include the price of Bitcoin and network hashprice, which directly affect mining revenue, as well as execution on the $129 million financing and any further equity issuance. The outcome of the Swedish VAT appeal and the trajectory of AI infrastructure financing costs also remain important. Analyst consensus on HIVE has remained favorable overall, but a wide gap between the average price target and the current share price reflects ongoing uncertainty about valuation and funding.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The RSI Indicator for HIVE moved into overbought territory on November 05, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +6.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIVE advanced for three days, in 211 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
HIVE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIVE as a result. In 67 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The Moving Average Convergence Divergence Histogram (MACD) for HIVE turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 30 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
HIVE moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HIVE crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
The 50-day moving average for HIVE moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for HIVE entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.972) is normal, around the industry mean (3.008). P/E Ratio (9.174) is within average values for comparable stocks, (6.695). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (9.358) among similar stocks. P/S Ratio (2.169) is also within normal values, averaging (16.899).
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. HIVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of cloud networking and enterprise Wi-Fi solution
Industry InvestmentBanksBrokers